Effect of polysorbate 80 on oritavancin binding to plastic surfaces: Implications for susceptibility testing

被引:92
作者
Arhin, Francis F. [1 ]
Sarmiento, Ingrid [1 ]
Belley, Adam [1 ]
McKay, Geoffrey A. [1 ]
Draghi, Deborah C.
Grover, Parveen
Sahm, Daniel F.
Parr, Thomas R., Jr. [1 ]
Moeck, Gregory [1 ]
机构
[1] Targanta Therapeut, Dept Biol, St Laurent, PQ H4S 2A1, Canada
关键词
D O I
10.1128/AAC.01513-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Oritavancin, a semisynthetic lipoglycopeptide with activity against gram-positive bacteria, has multiple mechanisms of action, including the inhibition of cell wall synthesis and the perturbation of the membrane potential. Approved guidelines for broth microdilution MIC assays with dalbavancin, another lipoglycopeptide, require inclusion of 0.002% polysorbate 80. To investigate the potential impact of polysorbate 80 on oritavancin susceptibility assays, we quantified the recovery of [C-14]oritavancin from susceptibility assay plates with and without polysorbate 80 and examined the effect of the presence of polysorbate 80 on the oritavancin MICs for 301 clinical isolates from the genera Staphylococcus, Enterococcus, and Streptococcus. In the absence of polysorbate 80, [C-14] oritavancin was rapidly lost from solution in susceptibility assay test plates: 9% of the input drug was recovered in broth at 1 h when [C-14]oritavancin was tested at 1 mu g/ml. Furthermore, proportionately greater losses were observed at lower oritavancin concentrations, suggesting saturable binding of oritavancin to surfaces. The inclusion of 0.002% polysorbate 80 or 2% lysed horse blood permitted the recovery of 80 to 100% [C-14] oritavancin at 24 h for all drug concentrations tested. Concordantly, oritavancin MIC(90)s for streptococcal isolates, as determined in medium containing 2% lysed horse blood, were identical with and without polysorbate 80. In stark contrast, polysorbate 80 reduced the oritavancin MIC(90)s by 16- to 32-fold for clinical isolates of enterococci and staphylococci, which are typically cultured without blood. The results presented here provide evidence that the MIC data for oritavancin in the current literature significantly underestimate the potency of oritavancin in vitro. Moreover, the combination of data from MIC and [C-14] oritavancin recovery studies supports the revision of the oritavancin broth microdilution method to include polysorbate 80 throughout the assay.
引用
收藏
页码:1597 / 1603
页数:7
相关论文
共 20 条
[1]   Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an Investigational glycopeptide with potent gram-positive activity [J].
Anderegg, TR ;
Biedenbach, DJ ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) :2795-2796
[2]  
ARHIN F, 2007, 17 EUR C CLIN MICR I
[3]   RAMOPLANIN SUSCEPTIBILITY TESTING CRITERIA [J].
BARRY, AL ;
PFALLER, MA ;
FUCHS, PC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1932-1935
[4]  
Clinical and Laboratory Standards Institute, 2008, M100S18 CLIN LAB STA
[5]  
Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE
[6]   Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms [J].
Fritsche, Thomas R. ;
Rennie, Robert P. ;
Goldstein, Beth P. ;
Jones, Ronald N. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2988-2990
[7]   In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates [J].
Garcia-Garrote, F ;
Cercenado, E ;
Alcala, L ;
Bouza, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2452-2455
[8]   Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004) [J].
Jones, RN ;
Stilwell, MG ;
Sader, HS ;
Fritsche, TR ;
Goldstein, BP .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (02) :149-153
[9]   Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide [J].
Jones, RN ;
Streit, JM ;
Fritsche, TR .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (02) :197-199
[10]   Influence of polysorbate-80 when determining the tigecycline MIC by the reference method [J].
Jones, Ronald N. ;
Knapp, Cindy C. ;
Dowzicky, Michael J. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (01) :145-146